- Home
- OSK vs MDGL Comparison
OSK vs MDGL Comparison
Compare OSK & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSK
- MDGL
- Stock Information
- Founded
- OSK 1917
- MDGL 2011
- Country
- OSK United States
- MDGL United States
- Employees
- OSK N/A
- MDGL N/A
- Industry
- OSK Auto Manufacturing
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- OSK Consumer Discretionary
- MDGL Health Care
- Exchange
- OSK Nasdaq
- MDGL Nasdaq
- Market Cap
- OSK 5.6B
- MDGL 6.1B
- IPO Year
- OSK N/A
- MDGL N/A
- Fundamental
- Price
- OSK $135.94
- MDGL $427.05
- Analyst Decision
- OSK Buy
- MDGL Strong Buy
- Analyst Count
- OSK 12
- MDGL 10
- Target Price
- OSK $138.08
- MDGL $474.67
- AVG Volume (30 Days)
- OSK 539.0K
- MDGL 349.9K
- Earning Date
- OSK 10-29-2025
- MDGL 10-30-2025
- Dividend Yield
- OSK 1.50%
- MDGL N/A
- EPS Growth
- OSK N/A
- MDGL N/A
- EPS
- OSK 9.96
- MDGL N/A
- Revenue
- OSK $10,384,400,000.00
- MDGL $515,547,000.00
- Revenue This Year
- OSK N/A
- MDGL $394.12
- Revenue Next Year
- OSK $5.22
- MDGL $57.74
- P/E Ratio
- OSK $13.64
- MDGL N/A
- Revenue Growth
- OSK 0.16
- MDGL 3421.98
- 52 Week Low
- OSK $76.82
- MDGL $200.63
- 52 Week High
- OSK $144.30
- MDGL $457.16
- Technical
- Relative Strength Index (RSI)
- OSK 51.56
- MDGL 59.53
- Support Level
- OSK N/A
- MDGL $418.36
- Resistance Level
- OSK $139.96
- MDGL $440.90
- Average True Range (ATR)
- OSK 2.48
- MDGL 13.53
- MACD
- OSK -5.93
- MDGL -4.66
- Stochastic Oscillator
- OSK 94.21
- MDGL 22.40
About OSK Oshkosh Corporation (Holding Company)Common Stock
Oshkosh Corp is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms. The company had manufactured joint light tactical vehicles for the U.S. Department of Defense. The company reports in three segments: Access, Vocational and Defense. It derives maximum revenue from Access Segment.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.